{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:59:43Z","timestamp":1791928783181,"version":"4.3.4"},"reference-count":70,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2021,5,20]]},"DOI":"10.1167\/iovs.62.6.21","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T11:47:55Z","timestamp":1621511275000},"page":"21","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of Retinal Ganglion Cell Loss By a Novel ROCK Inhibitor (E212) in Ischemic Optic Nerve Injury Via Antioxidative and Anti-Inflammatory Actions"],"prefix":"10.1167","volume":"62","author":[{"given":"Yao-Tseng","family":"Wen","sequence":"first","affiliation":[{"name":"Institute of Eye Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Wen","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Peng","family":"Liu","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Chen","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Mu","family":"Tu","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrong-Shiong","family":"Hwang","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsun","family":"Chen","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ru","family":"Chen","sequence":"additional","affiliation":[{"name":"Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keh-Liang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medical laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chieh","family":"Ho","sequence":"additional","affiliation":[{"name":"Institute of Eye Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Ching","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Kung","family":"Tsai","sequence":"additional","affiliation":[{"name":"Institute of Eye Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"},{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan"},{"name":"Doctoral Degree Program in Translational Medicine, Tzu Chi University and Academia Sinica, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00041327-199403000-00011","article-title":"Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California","volume":"14","author":"Johnson","year":"1994","journal-title":"J Neuroophthalmol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0002-9394(14)70999-7","article-title":"Incidence of nonarteritic anterior ischemic optic neuropathy","volume":"123","author":"Hattenhauer","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"e3172","DOI":"10.1038\/cddis.2017.566","article-title":"Soluble P-selectin promotes retinal ganglion cell survival through activation of Nrf2 signaling after ischemia injury","volume":"8","author":"Kapupara","year":"2017","journal-title":"Cell Death and Disease"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ajo.2016.08.006","article-title":"Increased risk of stroke in patients with nonarteritic anterior ischemic optic neuropathy: a nationwide retrospective cohort study","volume":"170","author":"Lee","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1056\/NEJMra1413352","article-title":"Ischemic optic neuropathies","volume":"372","author":"Biousse","year":"2015","journal-title":"N Engl J Med"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00041327-200306000-00012","article-title":"Pathogenesis of nonarteritic anterior ischemic optic neuropathy","volume":"23","author":"Arnold","year":"2003","journal-title":"J Neuroophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0002-9394(14)70067-4","article-title":"Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders","volume":"117","author":"Hayreh","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.preteyeres.2008.11.002","article-title":"Ischemic optic neuropathy","volume":"28","author":"Hayreh","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jocn.2009.04.002","article-title":"Non-arteritic anterior ischaemic optic neuropathy: a review and update","volume":"16","author":"Kerr","year":"2009","journal-title":"J Clin Neurosci"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/0301-4738.77024","article-title":"Management of ischemic optic neuropathies","volume":"59","author":"Hayreh","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0002-9394(14)73478-6","article-title":"Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy","volume":"116","author":"Burde","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/archopht.1996.01100130484027","article-title":"Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy","volume":"114","author":"Levin","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.brainres.2008.12.075","article-title":"Optic nerve infarction and post-ischemic inflammation in the rodent model of anterior ischemic optic neuropathy (rAION)","volume":"1264","author":"Zhang","year":"2009","journal-title":"Brain Res"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.exer.2010.05.021","article-title":"Axonal degeneration, regeneration and ganglion cell death in a rodent model of anterior ischemic optic neuropathy (rAION)","volume":"91","author":"Zhang","year":"2010","journal-title":"Exp Eye Res"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/archophthalmol.2011.351","article-title":"Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model","volume":"129","author":"Salgado","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fneur.2014.00122","article-title":"Translational preclinical research may lead to improved medical management of non-arteritic anterior ischemic optic neuropathy","volume":"5","author":"Nicholson","year":"2014","journal-title":"Front Neurol"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2011.04.026","article-title":"Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia\u2013reperfusion injury","volume":"51","author":"Wei","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/jnc.12325","article-title":"Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death","volume":"127","author":"Himori","year":"2013","journal-title":"J Neurochem"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/jnc.13064","article-title":"Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion","volume":"133","author":"Xu","year":"2015","journal-title":"J Neurochem"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1042\/BST0330891","article-title":"Rho GTPases and the control of cell behaviour","volume":"33","author":"Hall","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2337\/db07-1768","article-title":"Rho kinase inhibition: a new approach for treating diabetic nephropathy?","volume":"57","author":"Bach","year":"2008","journal-title":"Diabetes"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tips.2005.12.002","article-title":"Targeting Rho and Rho-kinase in the treatment of cardiovascular disease","volume":"27","author":"Budzyn","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.freeradbiomed.2012.07.018","article-title":"Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype","volume":"53","author":"Ramamoorthy","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/neu.2010.30.issue-3","article-title":"Synergistic effects of bone marrow stromal cells and a Rho kinase (ROCK) inhibitor, fasudil on axon regeneration in rat spinal cord injury","volume":"30","author":"Chiba","year":"2010","journal-title":"Neuropathology"},{"key":"bib25","doi-asserted-by":"crossref","first-page":"214587","DOI":"10.1155\/2014\/214587","article-title":"The prognostic values of leukocyte Rho kinase activity in acute ischemic stroke","volume":"2014","author":"Cheng","year":"2014","journal-title":"Biomed Res Int"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2174\/156802609789044452","article-title":"Rho kinase (ROCK) inhibitors and their application to Inflammatory Disorders","volume":"9","author":"LoGrasso","year":"2009","journal-title":"Curr Top Med Chem"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1517\/13543784.2013.840288","article-title":"Rho-kinase inhibitors offer a new approach in the treatment of glaucoma","volume":"23","author":"Challa","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brainres.2013.07.053","article-title":"RhoA activity and post-ischemic inflammation in an experimental model of adult rodent anterior ischemic optic neuropathy","volume":"1534","author":"Fard","year":"2013","journal-title":"Brain Res"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","article-title":"Rho kinase (ROCK) inhibitors and their therapeutic potential","volume":"59","author":"Feng","year":"2016","journal-title":"J Med Chem"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ejphar.2008.01.056","article-title":"Rho kinase inhibitors: a novel therapeutical intervention in asthma?","volume":"585","author":"Schaafsma","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/embor.2012.127","article-title":"Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy","volume":"13","author":"Rath","year":"2012","journal-title":"EMBO Rep"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1517\/14728214.2010.480973","article-title":"The future is today: emerging drugs for the treatment of erectile dysfunction","volume":"15","author":"Albersen","year":"2010","journal-title":"Expert Opin Emerg Drugs"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"11776","DOI":"10.1074\/jbc.C900014200","article-title":"Targeted disruption of ROCK1 causes insulin resistance in vivo","volume":"284","author":"Lee","year":"2009","journal-title":"J Biol Chem"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/ki.2010.428","article-title":"Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure","volume":"79","author":"Komers","year":"2011","journal-title":"Kidney Int"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrd1719","article-title":"Rho kinase, a promising drug target for neurological disorders","volume":"4","author":"Mueller","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1167\/iovs.13-13842","article-title":"The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma","volume":"55","author":"Yamamoto","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pneurobio.2015.06.002","article-title":"Moons L, Van Hove I. Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics","volume":"131","author":"Van de Velde","year":"2015","journal-title":"Prog Neurobiol"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2013.06.004","article-title":"Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease","volume":"58","author":"Rodriguez-Perez","year":"2013","journal-title":"Neurobiol Dis"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"e1225","DOI":"10.1038\/cddis.2014.191","article-title":"ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS","volume":"5","author":"Koch","year":"2014","journal-title":"Cell Death Dis"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/jcph.v56.6","article-title":"Intravitreal injection of a Rho-kinase inhibitor (fasudil) for recent-onset nonarteritic anterior ischemic optic neuropathy","volume":"56","author":"Sanjari","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1167\/iovs.16-20979","article-title":"Neuroprotective effects of Omega-3 polyunsaturated fatty acids in a rat model of anterior ischemic optic neuropathy","volume":"58","author":"Georgiou","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1167\/iovs.14-15999","article-title":"Efficacy of intravitreal injections of antivascular endothelial growth factor agents in a rat model of anterior ischemic optic neuropathy","volume":"56","author":"Huang","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1167\/iovs.15-19023","article-title":"Efficacy of intravitreal injections of triamcinolone acetonide in a rodent model of nonarteritic anterior ischemic optic neuropathy","volume":"57","author":"Huang","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.preteyeres.2011.02.003","article-title":"Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models","volume":"30","author":"Bernstein","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.exer.2008.06.004","article-title":"Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats","volume":"87","author":"Tsai","year":"2008","journal-title":"Exp Eye Res"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.exer.2010.01.004","article-title":"Anti-apoptotic effects of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush are PI3K\/AKT-dependent","volume":"90","author":"Tsai","year":"2010","journal-title":"Exp Eye Res"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.exer.2010.12.008","article-title":"Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats","volume":"92","author":"Huang","year":"2011","journal-title":"Exp Eye Res"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.exer.2014.12.014","article-title":"Protective effects of systemic treatment with methylprednisolone in a rodent model of non-arteritic anterior ischemic optic neuropathy (rAION)","volume":"131","author":"Huang","year":"2015","journal-title":"Exp Eye Res"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.neuint.2012.11.009","article-title":"Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury","volume":"62","author":"Manzanero","year":"2013","journal-title":"Neurochem Int"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fneur.2011.00023","article-title":"Neuroprotective effect of hyperbaric oxygen therapy on anterior ischemic optic neuropathy","volume":"2","author":"Avraham-Lubin","year":"2011","journal-title":"Front Neurol"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/jnc.12681","article-title":"Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions","volume":"129","author":"Gibson","year":"2014","journal-title":"J Neurochem"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/archopht.126.11.1582","article-title":"Hypothesis: A venous etiology for nonarteritic anterior ischemic optic neuropathy","volume":"126","author":"Levin","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.exer.2005.04.008","article-title":"Heterogeneous populations of microglia\/macrophages in the retina and their activation after retinal ischemia and reperfusion injury","volume":"81","author":"Zhang","year":"2005","journal-title":"Exp Eye Res"},{"key":"bib54","first-page":"1193","article-title":"Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood-optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION)","volume":"9","author":"Wen","year":"2016","journal-title":"Dis Model Mech"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1167\/iovs.16-21017","article-title":"Early methylprednisolone treatment can stabilize the blood-optic nerve barrier in a rat model of anterior ischemic optic neuropathy (rAION)","volume":"58","author":"Huang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1167\/iovs.07-1651","article-title":"A primate model of nonarteritic anterior ischemic optic neuropathy","volume":"49","author":"Chen","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.2013.39.issue-1","article-title":"Review: activation patterns of microglia and their identification in the human brain","volume":"39","author":"Boche","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.v173.4","article-title":"Microglial M1\/M2 polarization and metabolic states","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br J Pharmacol"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"e107063","DOI":"10.1371\/journal.pone.0107063","article-title":"Induction of murine macrophage M2 polarization by cigarette smoke extract via the JAK2\/STAT3 pathway","volume":"9","author":"Yuan","year":"2014","journal-title":"PLoS One"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.molimm.2018.05.028","article-title":"Erythropoietin alleviates hyperglycaemia-associated inflammation by regulating macrophage polarization via the JAK2\/STAT3 signalling pathway","volume":"101","author":"Cui","year":"2018","journal-title":"Mol Immunol"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1742-2094-7-54","article-title":"The role of the JAK2-STAT3 pathway in pro-inflammatory responses of EMF-stimulated N9 microglial cells","volume":"7","author":"Yang","year":"2010","journal-title":"J Neuroinflammation"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2017.10.002","article-title":"(+)-Borneol improves the efficacy of edaravone against DSS-induced colitis by promoting M2 macrophages polarization via JAK2-STAT3 signaling pathway","volume":"53","author":"Zhang","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"e54841","DOI":"10.1371\/journal.pone.0054841","article-title":"Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2017.03.025","article-title":"L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: involvement of NF-kappaB inhibition and Nrf2 pathway activation","volume":"806","author":"Chen","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"bib65","article-title":"PTEN and AKT\/GSK-3\u00df\/CRMP-2 signaling pathway are involved in neuronal apoptosis and axonal injury in early brain injury after SAH in rats [published online ahead of print June 18, 2020]","author":"Chen","journal-title":"Genes Dis"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cell.2004.11.012","article-title":"GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity","volume":"120","author":"Yoshimura","year":"2005","journal-title":"Cell"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5625\/lar.2013.29.2.63","article-title":"Ferulic acid regulates the AKT\/GSK-3\u00df\/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model","volume":"29","author":"Gim","year":"2013","journal-title":"Lab Anim Res"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s12035-012-8385-3","article-title":"CRMP-2 is involved in axon growth inhibition induced by RGMa in vitro and in vivo","volume":"47","author":"Wang","year":"2013","journal-title":"Mol Neurobiol"},{"key":"bib69","first-page":"342","article-title":"TollLike receptor 4 promotes the phosphorylation of CRMP2 via the activation of Rhokinase in MCAO rats","volume":"18","author":"Li","year":"2018","journal-title":"Mol Med Rep"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.1128\/MCB.25.22.9973-9984.2005","article-title":"Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones","volume":"25","author":"Arimura","year":"2005","journal-title":"Mol Cell Biol"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:25Z","timestamp":1791927085000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,5,3]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.62.6.21","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,20]]}}}